Act-541468 治験審査委員会
WebOct 26, 2024 · A study in healthy male subjects to investigate whether administration of ACT-541468 can affect the fate in the body (amount and time of presence in the blood)...。治験登録。 ICH GCP。 WebJul 20, 2016 · 药品：ACT-541468. 含有 ACT-541468 的口服胶囊，浓度为 5 mg、10 mg 或 25 mg. 药品：安慰剂. 配套ACT-541468胶囊的口服胶囊. 实验性的：序列 2. 每个受试者 …
Act-541468 治験審査委員会
Did you know?
WebOct 19, 2024 · A Single-center, Open-label, Single-dose, Phase 1 Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic … WebSep 28, 2016 · Three other subjects Subjects received ACT-541468 formulation B during Period 1 and ACT-541468 formulation A during Period 2. Two additional subjects …
WebApr 8, 2024 · Double-blind to the administration of ACT-541468 (participant). Single- and double-blind to the administration of ACT-541468 (Investigator, single-/double blind is dependent on treatment arm team). Single-blind study with the inclusion of two double-blind nested crossover parts, i.e., subjects will remain blinded to all administrations of ACT ... WebOct 4, 2024 · イドルシア ファーマシューティカルズ ジャパンは10月3日、不眠症治療薬・ダリドレキサント（一般名、開発コード：act ...
Web臨床研究等提出・公開システム. 臨床研究・治験計画情報の詳細情報です。. 不眠障害患者を対象として、ACT-541468を1日1回就寝前に4週間投与した際の主観的総睡眠時間及 … WebApr 12, 2024 · Treatment (5 mg, 10 mg, 25 mg, 50 mg ACT-541468 and placebo) was administered on Days1&2 of each of the five treatment periods, followed by a 5-12-day washout. The main efficacy endpoints were the change from baseline (placebo run-in) in WASO (primary) and LPS (secondary) to Days1&2 (mean of PSG on Days1&2).
Web加わった不眠症治療剤act-541468の開発を推進します。 ・ 中国での高トリグリセリド血症治療剤MND-21の開発を推進します。 ・ 開発品と製品の育薬を推進し、効能追加や剤 …
WebApr 5, 2024 · A Single-center, Double-blind, Placebo-controlled, Randomized Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of Single- … newsround sign upWebJul 16, 2024 · Use of drugs which might interfere with the PK of ACT-541468 (moderate to strong CYP3A4 inhibitors or inducers). Any circumstances or conditions, which, in the … newsround shamima begumWebMay 17, 2024 · A bioequivalence study of ACT-541468 25 and 50mg tablet. Basic Information. Recruitment status: Not Recruiting: Health condition(s) or Problem(s) … midkin station in the 1930sWeb治験審査委員会は、治験を行う医療機関1ヶ所あたり1つの委員会が設置されています。. そして実際の審査は、治験の実施前に行われます。. IRB（Institutional Review Board） … newsround space newsnewsround soundtrackWebJul 16, 2024 · 肝癌、原发性胆汁性肝硬化或任何形式的胆汁淤积性疾病。. 使用可能干扰 ACT-541468 PK 的药物（中度至强 CYP3A4 抑制剂或诱导剂）。. 研究者认为可能影响完全参与研究或遵守方案的任何情况或条件。. 健康受试者的附加排除标准（A 组）. 任何不稳定疾病的病史或 ... midkinis to go with high waisted bottomsWeb文献「二重オレキシン受容体拮抗薬act-541468とcyp3a4および食物との相互作用ポテンシャル:2つの相互作用研究からの結果【jst・京大機械翻訳】」の詳細情報です。j-global … newsround special films